pretickt

When does Dexcom report earnings?

DexCom, Inc. · end-of-day data as of Nov 13, 2026

Dexcom
DXCM · $31.08B
$83.33+2.4%
Nov 13, 2026 · close
$80$90SepOctNov9:3016:003 months -7.0%Nov 13 · close
▲ 6
  • PT$94.75 +13.7%
  • ConsensusBuy · 29
  • News
  • MAs3 of 4
  • MACD0.17
  • Sector▲ +15.9%
Neutral
  • Earnings in90d
  • P/E32.7x
  • RSI51
  • Support-1.2%
  • Resistance+4.6%
  • Off 52w high-10.0%
  • Volume0.6x
  • Bollingerupper half
  • FCF yield+3.5%
  • P/E vs own+9.9%
  • P/E vs sector+1.4%
  • Trendsideways
  • 52w range$57–$93
  • ATR+3.6%
  • Off ATH-49.5%
▼ 1
  • Insiders-$4.33M

Updates with the 15-min delayed price. Not a forecast or investment advice.

Dexcom DXCM reports its next earnings on Thursday, Feb 11, 2027, after the close, an estimated date the company has not confirmed yet. Analysts expect EPS of $0.71 on revenue of $1.38B. Dexcom beat the EPS estimate in 6 of its last 8 reports, and the stock moved ±8.9% on average the session after. The last report, on Oct 29, 2026: EPS of $0.73 against $0.68 expected and revenue of $1.34B against $1.33B; the stock rose 3.0% the next session.

The stock around its reports

⇔⇕$57.28$68.15$79.03$89.90Nov 24Apr 25Sep 25Feb 26Jul 26Dec 26AAEEEEAAEEEEE

Last close $83.33 · +18.5% over 2y · E earnings · D dividend · S split · A analyst rating change

Quarterly results

Q3 FY2026: Revenue +11.2% year over year, free cash flow 20.3% of revenue, operating margin 24.3%.

RevenueFree cash flow
Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Q3 FY2026Sep 30, 2026$1.34B0.72$273M64.3%24.3%20.5%
Q2 FY2026Jun 30, 2026$1.31B0.64$185M63.4%24.3%19.0%
Q1 FY2026Mar 31, 2026$1.19B0.51$449M62.9%21.4%16.7%
Q4 FY2025Dec 31, 2025$1.26B0.68$192M62.9%25.6%21.2%
Q3 FY2025Sep 30, 2025$1.21B0.70$579M60.5%20.1%23.5%
Q2 FY2025Jun 30, 2025$1.16B0.45$209M59.5%18.4%15.5%
Q1 FY2025Mar 31, 2025$1.04B0.27$96.8M56.9%12.9%10.2%
Q4 FY2024Dec 31, 2024$1.11B0.38$177M58.9%17.0%13.6%